Scientists create virus killing water
Scientists have developed a form of water which they claim could kill vast quantities of bacteria, viruses and fungi, including many that are unaffected by bleach.world Updated: May 25, 2007 11:29 IST
Scientists have developed a form of water which they claim could kill vast quantities of bacteria, viruses and fungi, including many that are unaffected by bleach.
The water called Dermacyn, developed by California based Oculus, is recommended for external use only and should not be drunk although its makers say they did not find it causing any harm to those who drank it.
Dubbed as miracle water by its maker, Dermacyn costs around 16 pounds a bottle and has a shelf life of two years.
In trials on diabetic patients it was more effective in clearing up hard to treat foot ulcers than existing treatments. Ulcers took 55 days to heal when treated with iodine and antibiotics while they took 43 days to heal when Dermacyn was used.
"When you spray it on, you see the treated tissue pink up and go beefy, which is good because it means the oxygen supply has resumed," said Dr Cheryl Bongiovanni who used the product on more than 1,000 patients in Oregon.
Other tests have shown that small amounts of the liquid can kill vast quantities of bacteria, viruses and fungi.
Some of the vulnerable germs include hospital super bugs meticillin resistent staphylococcus aureus (MRSA) and clostridium difficile, food poisoning bacteria e.coli and salmonella, the tuberculosis virus and human immuno deficiency (HIV) virus.
The liquid is a chemically altered version of salty water, which is full of negatively charged particles.
These are capable of killing dangerous micro-organisms by punching holes in their cell walls.
While bacteria and viruses are quickly dispatched, human cells are left intact because they are packed too tightly together to be attacked, according to online edition of Daily Mail.
The potion, which is available as a solution and a spray, is on sale in the U.S. and has been licensed for over the counter sale in Britain.
Professor Andrew Boulton, who is investigating the solution's wound healing effects at the Manchester Royal Infirmary, said initial signs were "promising".